This chapter gives an overview of hemophilia A and B, and emphasizes the nurses' role as part of the comprehensive care provided by HTCs.
This online tool provides comprehensive care teams with information on helping patients with hemophilia maintain healthy joints.
Researchers and clinicians should register now for FVIII inhibitor symposium in Ohio.
The latest online educational activity from Medscape, "Assessing Your Understanding of Key Issues in Hemophilia," became available on Monday, March 23, 2015.
Study finds that men with severe hemophilia A and an inhibitor are at an increased risk of death from bleeding-related complications.
Female carriers of hemophilia and those with mild, moderate and severe hemophilia show early signs of bleeding into joints, according to CDC study.
Lentivirus gene therapy in dogs with hemophilia markedly lowers bleeding rates.
This chapter provides an overview of inhibitors, antibodies to factor product, including the causes and conditions underlying this complication.
Researchers use bio-engineered lettuce leaves to deliver high volumes of factor IX in dogs with hemophilia.
Check out the new PDF available for the Nurses' Guide to Bleeding Disorders chapter, "von Willebrand Disease."
eNewsletter Sign Up
Steps for Living
Victory for Women
Donate Your Car